These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 26028263)
21. Intravenous iron supplementation in distance runners with low or suboptimal ferritin. Garvican LA; Saunders PU; Cardoso T; Macdougall IC; Lobigs LM; Fazakerley R; Fallon KE; Anderson B; Anson JM; Thompson KG; Gore CJ Med Sci Sports Exerc; 2014 Feb; 46(2):376-85. PubMed ID: 23872938 [TBL] [Abstract][Full Text] [Related]
22. IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia. Beck-da-Silva L; Piardi D; Soder S; Rohde LE; Pereira-Barretto AC; de Albuquerque D; Bocchi E; Vilas-Boas F; Moura LZ; Montera MW; Rassi S; Clausell N Int J Cardiol; 2013 Oct; 168(4):3439-42. PubMed ID: 23680589 [TBL] [Abstract][Full Text] [Related]
23. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. Okonko DO; Grzeslo A; Witkowski T; Mandal AK; Slater RM; Roughton M; Foldes G; Thum T; Majda J; Banasiak W; Missouris CG; Poole-Wilson PA; Anker SD; Ponikowski P J Am Coll Cardiol; 2008 Jan; 51(2):103-12. PubMed ID: 18191732 [TBL] [Abstract][Full Text] [Related]
24. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients. Chen YC; Hung SC; Tarng DC Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299 [TBL] [Abstract][Full Text] [Related]
25. Rationale and design of the IRON-HF study: a randomized trial to assess the effects of iron supplementation in heart failure patients with anemia. Beck-da-Silva L; Rohde LE; Pereira-Barretto AC; de Albuquerque D; Bocchi E; Vilas-Boas F; Moura LZ; Montera MW; Rassi S; Clausell N J Card Fail; 2007 Feb; 13(1):14-7. PubMed ID: 17338998 [TBL] [Abstract][Full Text] [Related]
26. Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review. Peyrin-Biroulet L; Williet N; Cacoub P Am J Clin Nutr; 2015 Dec; 102(6):1585-94. PubMed ID: 26561626 [TBL] [Abstract][Full Text] [Related]
27. Monitoring iron status in end-stage renal disease patients on hemodialysis. Rafi A; Karkar A; Abdelrahman M Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895 [TBL] [Abstract][Full Text] [Related]
28. Intravenous iron dextran therapy in patients with iron deficiency and normal renal function who failed to respond to or did not tolerate oral iron supplementation. Barton JC; Barton EH; Bertoli LF; Gothard CH; Sherrer JS Am J Med; 2000 Jul; 109(1):27-32. PubMed ID: 10936475 [TBL] [Abstract][Full Text] [Related]
29. Management of iron deficiency and anemia after Roux-en-Y gastric bypass surgery: an observational study. Malone M; Alger-Mayer S; Lindstrom J; Bailie GR Surg Obes Relat Dis; 2013; 9(6):969-74. PubMed ID: 23499191 [TBL] [Abstract][Full Text] [Related]
30. A randomized controlled trial of oral heme iron polypeptide versus oral iron supplementation for the treatment of anaemia in peritoneal dialysis patients: HEMATOCRIT trial. Barraclough KA; Brown F; Hawley CM; Leary D; Noble E; Campbell SB; Isbel NM; Mudge DW; van Eps CL; Johnson DW Nephrol Dial Transplant; 2012 Nov; 27(11):4146-53. PubMed ID: 22962411 [TBL] [Abstract][Full Text] [Related]
31. Iron Bisglycinate Chelate and Polymaltose Iron for the Treatment of Iron Deficiency Anemia: A Pilot Randomized Trial. Name JJ; Vasconcelos AR; Valzachi Rocha Maluf MC Curr Pediatr Rev; 2018; 14(4):261-268. PubMed ID: 30280670 [TBL] [Abstract][Full Text] [Related]
32. Improvement of anemia with erythropoietin and intravenous iron reduces sleep-related breathing disorders and improves daytime sleepiness in anemic patients with congestive heart failure. Zilberman M; Silverberg DS; Bits I; Steinbruch S; Wexler D; Sheps D; Schwartz D; Oksenberg A Am Heart J; 2007 Nov; 154(5):870-6. PubMed ID: 17967592 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and Safety of Oral Supplementation with Liposomal Iron in Non-Dialysis Chronic Kidney Disease Patients with Iron Deficiency. Cesarano D; Borrelli S; Campilongo G; D'Ambra A; Papadia F; Garofalo C; De Marco A; Marzano F; Ruotolo C; Gesualdo L; Cirillo P; Minutolo R Nutrients; 2024 Apr; 16(9):. PubMed ID: 38732502 [TBL] [Abstract][Full Text] [Related]
34. Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron. Toblli JE; Di Gennaro F; Rivas C Heart Lung Circ; 2015 Jul; 24(7):686-95. PubMed ID: 25666998 [TBL] [Abstract][Full Text] [Related]
35. [Current recommendations for the treatment of iron deficiency anemia]. Schaefer RM; Huch R; Krafft A; Rev Med Suisse; 2007 Apr; 3(105):874-80. PubMed ID: 17514929 [TBL] [Abstract][Full Text] [Related]
36. Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease. Wikström B; Bhandari S; Barany P; Kalra PA; Ladefoged S; Wilske J; Thomsen LL J Nephrol; 2011; 24(5):589-96. PubMed ID: 21240875 [TBL] [Abstract][Full Text] [Related]
37. Oral supplementation with NaFeEDTA reduces blood lead in postmenopausal but not premenopausal Korean women with anemia. Kim HS; Kim MK; Lee BK Nutrition; 2009 Jan; 25(1):66-71. PubMed ID: 18834721 [TBL] [Abstract][Full Text] [Related]
38. Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life. Befrits R; Wikman O; Blomquist L; Hjortswang H; Hammarlund P; Bajor A; Klintman D; Blom H Scand J Gastroenterol; 2013 Sep; 48(9):1027-32. PubMed ID: 23889159 [TBL] [Abstract][Full Text] [Related]
39. Correction of Iron Deficiency Anemia With Intravenous Iron Sucrose in Children With Inflammatory Bowel Disease. Danko I; Weidkamp M J Pediatr Gastroenterol Nutr; 2016 Nov; 63(5):e107-e111. PubMed ID: 27540710 [TBL] [Abstract][Full Text] [Related]
40. [Treatment of iron deficiency by a bolus intravenous iron dextran in peritoneal dialysis]. Ficheux M; Cuny P; Lecouf A; Ryckelynck JP; Hurault de Ligny B; Lobbedez T Nephrol Ther; 2011 Dec; 7(7):558-61. PubMed ID: 21715234 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]